316 related articles for article (PubMed ID: 38016738)
1. Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
Alqahtani A
Saudi Med J; 2023 Dec; 44(12):1222-1231. PubMed ID: 38016738
[TBL] [Abstract][Full Text] [Related]
2. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
3. Isolation and evaluation of the efficacy of bacteriophages against multidrug-resistant (MDR), methicillin-resistant (MRSA) and biofilm-producing strains of Staphylococcus aureus recovered from bovine mastitis.
Mohammadian F; Rahmani HK; Bidarian B; Khoramian B
BMC Vet Res; 2022 Nov; 18(1):406. PubMed ID: 36384653
[TBL] [Abstract][Full Text] [Related]
4. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
Aranaga C; Pantoja LD; Martínez EA; Falco A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
[TBL] [Abstract][Full Text] [Related]
5. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections
Kebriaei R; Lev KL; Shah RM; Stamper KC; Holger DJ; Morrisette T; Kunz Coyne AJ; Lehman SM; Rybak MJ
Microbiol Spectr; 2022 Apr; 10(2):e0041122. PubMed ID: 35348366
[TBL] [Abstract][Full Text] [Related]
7. Isolation and identification of specific bacteriophages against methicillin-resistant Staphylococcus aureus, extended-spectrum beta-lactamases-producing Escherichia coli, extended-spectrum beta-lactamases-producing Klebsiella pneumoniae, and multidrug-resistant Acinetobacter baumanniiin vitro.
Fanaei V; Validi M; Zamanzad B; Karimi A
FEMS Microbiol Lett; 2021 Nov; 368(19):. PubMed ID: 34718541
[TBL] [Abstract][Full Text] [Related]
8. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal Synergism between Phage YC#06 and Antibiotics: a Combination Strategy to Target Multidrug-Resistant Acinetobacter baumannii
Luo J; Xie L; Liu M; Li Q; Wang P; Luo C
Microbiol Spectr; 2022 Aug; 10(4):e0009622. PubMed ID: 35736241
[TBL] [Abstract][Full Text] [Related]
11. Phages for treatment of Staphylococcus aureus infection.
Samir S
Prog Mol Biol Transl Sci; 2023; 200():275-302. PubMed ID: 37739558
[TBL] [Abstract][Full Text] [Related]
12. Simple Two-step, High Yield Protocol for Isolation and Amplification of Bacteriophages Against Methicillin-resistant Staphylococcus Aureus (MRSA).
Khan A; Joshi H
Curr Protoc; 2022 Mar; 2(3):e395. PubMed ID: 35259286
[TBL] [Abstract][Full Text] [Related]
13. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
Royer S; Morais AP; da Fonseca Batistão DW
Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
[TBL] [Abstract][Full Text] [Related]
17. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
Usman SS; Uba AI; Christina E
Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
[TBL] [Abstract][Full Text] [Related]
19. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
Golkar Z; Bagasra O; Pace DG
J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
